October 13, 2016 / 6:16 AM / 9 months ago

BRIEF-Jubilant Life Sciences gets ANDA approval for Darifenacin ER tablets

1 Min Read

Oct 13 (Reuters) - Jubilant Life Sciences Ltd :

* Says Jubilant Life Sciences receives ANDA approval for Darifenacin ER tablets Source text: bit.ly/2dMoFFv Further company coverage: (Bengaluru newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below